Report overview
Antibiotics are medicines used to prevent and treat bacterial infections. Antibiotic resistance occurs,when the medicines used to treat infections caused by bacteria no longer work.
This report aims to provide a comprehensive presentation of the global market for Antibiotic Resistance Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antibiotic Resistance Biomarkers. This report contains market size and forecasts of Antibiotic Resistance Biomarkers in global, including the following market information:
Global Antibiotic Resistance Biomarkers Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Antibiotic Resistance Biomarkers market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Blood Biomarkers Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Antibiotic Resistance Biomarkers include Thermo Fisher Scientific, Qiagen, Abbott, Bio-Rad Laboratories, Cube Dx GmbH, GenMark Diagnostic, Merck, Creative Diagnostic and Roche, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Antibiotic Resistance Biomarkers companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Antibiotic Resistance Biomarkers Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Antibiotic Resistance Biomarkers Market Segment Percentages, by Type, 2022 (%)
Blood Biomarkers
Urine Biomarkers
Global Antibiotic Resistance Biomarkers Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Antibiotic Resistance Biomarkers Market Segment Percentages, by Application, 2022 (%)
Diagnostics
Drug Discovery
Personalized Medicine
Others
Global Antibiotic Resistance Biomarkers Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Antibiotic Resistance Biomarkers Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Antibiotic Resistance Biomarkers revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Antibiotic Resistance Biomarkers revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Thermo Fisher Scientific
Qiagen
Abbott
Bio-Rad Laboratories
Cube Dx GmbH
GenMark Diagnostic
Merck
Creative Diagnostic
Roche
HiMedia Laboratories
Danaher Corporatory
Outline of Major Chapters:
Chapter 1: Introduces the definition of Antibiotic Resistance Biomarkers, market overview.
Chapter 2: Global Antibiotic Resistance Biomarkers market size in revenue.
Chapter 3: Detailed analysis of Antibiotic Resistance Biomarkers company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Antibiotic Resistance Biomarkers in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
